Skip to main content
Bohn Stafleu van Loghum
ZOEKEN
MENU 1 2 3 4
main-content
Top

Tip

Swipe om te navigeren naar een ander artikel

Gepubliceerd in: Quality of Life Research 5/2017

18-11-2016 | Review

A review of the application, feasibility, and the psychometric properties of the individualized measures in cancer

Auteurs: Ala’ S. Aburub, Nancy E. Mayo

Gepubliceerd in: Quality of Life Research | Uitgave 5/2017

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Abstract

Purpose

To identify from the published literature the feasibility and the application of the individualized measures [Patient Generated Index (PGI), Schedule for the Evaluation of Individual Quality of Life (SEIQOL), and the short form of it (the direct weighting SEIQOL-DW)] in the context of cancer and to summarize the evidence on the psychometric properties of these measures.

Methods

Ovid Medline, PubMed, Embase, and CINAHL were searched up to April 2016. All studies were included if they reported information about the psychometric properties of the individualized measures and included patients diagnosed with any type of cancer at any age. Effect size (ES) was calculated to test for the responsiveness.

Results

Fifty-four full articles were reviewed. Full-text assessment of these articles resulted in 27 eligible studies that were included in our analysis. The majority of the studies (81%) reported data on the SEIQOL-DW, and only 15% on the PGI. Fourteen areas of quality-of-life (QOL) concerns were identified by patients using the PGI with the top 4 being family (90%), health (85%), finance (85%), and work (80%). At the global level, the correlation between the individualized and standard measures ranged from 0.45 to 0.49 and, at the symptom level, from 0.26 to 0.51. The ES of the individualized measures was high (ranged from 0.98 to 1.0) in the studies that expected high positive change compared to standard QOL measures (ES = 0.1).

Conclusion

Individualized measures are feasible and acceptable among people with cancer and could easily be incorporated clinically and used in a research context. Individualized measures are sensitive to change and cover a wide range of patients QOL concerns in comparison with standard measures.
volgende artikel The validation of a computer-adaptive test (CAT) for assessing health-related quality of life in children and adolescents in a clinical sample: study design, methods and first results of the Kids-CAT study
Literatuur
1.
2.
3.
Hoffman, B. (2005). survivors at work: A generation of progress. CA: A Cancer Journal for Clinicians, 55, 271–280.
4.
Smith, T., et al. (2007). The rationale, design, and implementation of the American Cancer Society’s studies of cancer survivors. Cancer, 109(1), 1–12. CrossRefPubMed
5.
Group, W. (1994). Development of the WHOQOL: Rationale and current status. International Journal of Mental Health, 23(3), 24–56. CrossRef
6.
7.
Cella, D. F. (1995). Measuring quality of life in palliative care. Seminars in Oncology, 22(2 Suppl 3), 73–81.   PubMed
8.
Schipper, H., Clinch, J. J., & Olweny, C. L. M. (1996). Quality of life studies: Definitions and conceptual issues. In B. Spilker (Ed.), Quality of life and pharmaco-economics in clinical trials (pp. 11–23). Philadelphia: Lippincott-Raven Publishers.
9.
Soni, M. K., & Cella, D. (2002). Quality of life and symptom measures in oncology: An overview. American Journal of Managed Care, 8(18 Suppl), S560–S573. PubMed
10.
Tanaka, T., & Gotay, C. C. (1998). Physicians’ and medical students’ perspectives on patients’ quality of life. Academic Medicine, 73(9), 1003–1005. CrossRefPubMed
11.
Patrick-Miller, L. J. (2003). Is there a role for the assessment of health-related quality of life in the clinical evaluation of novel cytostatic agents?: Commentary re: P. M. LoRusso, Improvements in quality of life and disease-related symptoms in phase I trials of the selective oral epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in non-small cell lung cancer and other solid tumors . Clinical Cancer Research, 9, 2040– 2048, 2003. Clinical Cancer Research, 9(6), 1990–1994, 2003.
12.
Sprangers, M. A. (2002). Quality-of-life assessment in oncology. Achievements and challenges. Acta Oncologica, 41(3), 229–237. CrossRefPubMed
13.
Osoba, D. (2004) Outcomes research applied. Paper presented at the ISOHRQL Symposium, Boston.
14.
Morris, J., Perez, D., & McNoe, B. (1998). The use of quality of life data in clinical practice. Quality of Life Research, 7(1), 85–91. CrossRefPubMed
15.
Taylor, K. M., et al. (1996). Physicians’ perspective on quality of life: An exploratory study of oncologists. Quality of Life Research, 5(1), 5–14. CrossRefPubMed
16.
Bezjak, A., et al. (2001). Oncologists’ use of quality of life information: Results of a survey of Eastern Cooperative Oncology Group physicians. Quality of Life Research, 10(1), 1–13. CrossRefPubMed
17.
18.
Aaronson, N. K., et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365–376. CrossRefPubMed
19.
20.
Ruta, D. A., et al. (1994). A new approach to the measurement of quality of life. The Patient-Generated Index. Medical Care, 32(11), 1109–1126. CrossRefPubMed
21.
Hickey, A. M., et al. (1996). A new short form individual quality of life measure (SEIQoL-DW): Application in a cohort of individuals with HIV/AIDS. BMJ, 313(7048), 29–33. CrossRefPubMedPubMedCentral
22.
McGee, H. M., et al. (1991). Assessing the quality of life of the individual: The SEIQoL with a healthy and a gastroenterology unit population. Psychological Medicine, 21(3), 749–759. CrossRefPubMed
23.
Tavernier, S. S., et al. (2011). Validity of the Patient Generated Index as a quality-of-life measure in radiation oncology. Oncology Nursing Forum, 38(3), 319–329. CrossRefPubMed
24.
Tavernier, S. S., Totten, A. M., & Beck, S. L. (2011). Assessing content validity of the patient generated index using cognitive interviews. Qualitative Health Research, 21(12), 1729–1738. CrossRefPubMed
25.
Lewis, S., et al. (2002). Quality of life issues identified by palliative care clients using two tools. Contemporary Nurse, 12(1), 31–41. CrossRefPubMed
26.
Llewellyn, C. D., McGurk, M., & Weinman, J. (2006). Head and neck cancer: To what extent can psychological factors explain differences between health-related quality of life and individual quality of life? British Journal of Oral and Maxillofacial Surgery, 44(5), 351–357. CrossRefPubMed
27.
Wettergren, L., Bjorkholm, M., & Langius-Eklof, A. (2005). Validation of an extended version of the SEIQoL-DW in a cohort of Hodgkin lymphoma’ survivors. Quality of Life Research, 14(10), 2329–2333. CrossRefPubMed
28.
Koch, T. (2000). Life quality vs the ‘quality of life’: Assumptions underlying prospective quality of life instruments in health care planning. Social Science and Medicine, 51(3), 419–427. CrossRefPubMed
29.
Browne, J. P., et al. (1994). Individual quality of life in the healthy elderly. Quality of Life Research, 3(4), 235–244. CrossRefPubMed
30.
Broadhead, J. K., Robinson, J. W., & Atkinson, M. J. (1998). A new quality-of-life measure for oncology: The SEIQoL. Journal of Psychosocial Oncology, 16(1), 21–35. CrossRef
31.
Campbell, S., & Whyte, F. (1999). The quality of life of cancer patients participating in phase I clinical trials using SEIQoL-DW. Journal of Advanced Nursing, 30(2), 335–343. CrossRefPubMed
32.
Camilleri-Brennan, J., Ruta, D. A., & Steele, R. J. (2002). Patient generated index: New instrument for measuring quality of life in patients with rectal cancer. World Journal of Surgery, 26(11), 1354–1359. CrossRefPubMed
33.
Waldron, D., et al. (1999). Quality-of-life measurement in advanced cancer: Assessing the individual. Journal of Clinical Oncology, 17(11), 3603–3611. CrossRefPubMed
34.
Mokkink, L. B., et al. (2010). The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. Journal of Clinical Epidemiology, 63(7), 737–745. CrossRefPubMed
35.
Mayo, N. E., et al. (2011). The extent to which common health-related quality of life indices capture constructs beyond symptoms and function. Quality of Life Research, 20(5), 621–627. CrossRefPubMed
36.
World Health Organization. (2001). International classification of functioning, disability and health, 2nd revision edn. Geneva: WHO.
37.
38.
Fayers, P. M., & Hand, D. J. (1997). Factor analysis, causal indicators and quality of life. Quality of Life Research, 6(2), 139–150. CrossRefPubMed
39.
Campbell, D. T., & Fiske, D. W. (1959). Convergent and discriminant validation by the multitrait-multimethod matrix. Psychological Bulletin, 56(2), 81–105. CrossRefPubMed
40.
Stephen Polgar, Shane A. Thomas, S. A. (2013). Introduction to research in the health sciences (6th ed.). Elsevier Health Sciences.
41.
Husted, J. A., et al. (2000). Methods for assessing responsiveness: A critical review and recommendations. Journal of Clinical Epidemiology, 53(5), 459–468. CrossRefPubMed
42.
Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). Hillsdale, NJ: Lawrence Erlbaum Associates.
43.
44.
Terwee, C. B., et al. (2012). Rating the methodological quality in systematic reviews of studies on measurement properties: A scoring system for the COSMIN checklist. Quality of Life Research, 21(4), 651–657. CrossRefPubMed
45.
Montgomery, C., et al. (2002). Individual quality of life in patients with leukaemia and lymphoma. Psychooncology, 11(3), 239–243. CrossRefPubMed
46.
Wettergren, L., et al. (2003). Individual quality of life in long-term survivors of Hodgkin’s lymphoma—A comparative study. Quality of Life Research, 12(5), 545–554. CrossRefPubMed
47.
Frick, E., et al. (2004). Individual quality of life of patients undergoing autologous peripheral blood stem cell transplantation. Psychooncology, 13(2), 116–124. CrossRefPubMed
48.
Levack, P., Graham, J., & Kidd, J. (2004). Listen to the patient: Quality of life of patients with recently diagnosed malignant cord compression in relation to their disability. Palliative Medicine, 18(7), 594–601. CrossRefPubMed
49.
Carlson, L. E., Bultz, B. D., & Morris, D. G. (2005). Individualized quality of life, standardized quality of life, and distress in patients undergoing a phase I trial of the novel therapeutic Reolysin (reovirus). Health and Quality of Life Outcomes, 3, 7. CrossRefPubMedPubMedCentral
50.
Sharpe, L., et al. (2005). Changes in quality of life in patients with advanced cancer: Evidence of response shift and response restriction. Journal of Psychosomatic Research, 58(6), 497–504. CrossRefPubMed
51.
Willener, R., & Hantikainen, V. (2005). Individual quality of life following radical prostatectomy in men with prostate cancer. Urologic Nursing, 25(2), 88–90. (95–100). PubMed
52.
Westerman, M., et al. (2006). Problems eliciting cues in SEIQoL-DW: Quality of life areas in small-cell lung cancer patients. Quality of Life Research, 15(3), 441–449. CrossRefPubMed
53.
Frick, E., Tyroller, M., & Panzer, M. (2007). Anxiety, depression and quality of life of cancer patients undergoing radiation therapy: A cross-sectional study in a community hospital outpatient centre. European Journal of Cancer Care, 16(2), 130–136. CrossRefPubMed
54.
Llewellyn, C., McGurk, M., & Weinman, J. (2007). The relationship between the Patient Generated Index (PGI) and measures of HR-QoL following diagnosis with head and neck cancer: Are illness and treatment perceptions determinants of judgment-based outcomes? British Journal of Health Psychology, 12(Pt 3), 421–437. CrossRefPubMed
55.
Ribi, K., et al. (2008). Individual versus standard quality of life assessment in a phase II clinical trial in mesothelioma patients: Feasibility and responsiveness to clinical changes. Lung Cancer, 61(3), 398–404. CrossRefPubMed
56.
Stone, P. C., et al. (2008). Measuring the individual quality of life of patients with prostate cancer. Prostate Cancer and Prostatic Diseases, 11(4), 390–396. CrossRefPubMed
57.
Wettergren, L., et al. (2008). Quality of life before and one year following stem cell transplantation using an individualized and a standardized instrument. Psychooncology, 17(4), 338–346. CrossRefPubMed
58.
Somani, B. K., et al. (2009). Quality of life and body image for bladder cancer patients undergoing radical cystectomy and urinary diversion—A prospective cohort study with a systematic review of literature. Urology, 74(5), 1138–1143. CrossRefPubMed
59.
Sundberg, K. K., et al. (2009). Positive and negative consequences of childhood cancer influencing the lives of young adults. European Journal of Oncology Nursing, 13(3), 164–170. CrossRefPubMed
60.
Sundberg, K. K., et al. (2010). Long-term survivors of childhood cancer report quality of life and health status in parity with a comparison group. Pediatric Blood & Cancer, 55(2), 337–343. CrossRef
61.
Stiel, S., et al. (2011). Assessment of quality of life in patients receiving palliative care: Comparison of measurement tools and single item on subjective well-being. Journal of Palliative Medicine, 14(5), 599–606. CrossRefPubMed
62.
Wettergren, L., et al. (2011). Comparing two versions of the Schedule for Evaluation of Individual Quality of Life in patients with advanced cancer. Acta Oncologica, 50(5), 648–652. CrossRefPubMed
63.
64.
65.
Tang, J. A., et al. (2014). The current trend of administering a patient-generated index in the oncological setting: A systematic review. Oncology Reviews, 8(1), 245. CrossRefPubMedPubMedCentral
66.
Martin, F., et al. (2007). Twelve years’ experience with the Patient Generated Index (PGI) of quality of life: A graded structured review. Quality of Life Research, 16(4), 705–715. CrossRefPubMed
67.
Wettergren, L., et al. (2009). The use, feasibility and psychometric properties of an individualised quality-of-life instrument: A systematic review of the SEIQoL-DW. Quality of Life Research, 18(6), 737–746. CrossRefPubMed
68.
Aburub, A. S., et al. (2016). Using a personalized measure (Patient Generated Index (PGI)) to identify what matters to people with cancer. Supportive Care in Cancer, 24(1), 437–445. CrossRefPubMed
69.
Patel, K. K., Veenstra, D. L., & Patrick, D. L. (2003). A review of selected patient-generated outcome measures and their application in clinical trials. Value Health, 6(5), 595–603. CrossRefPubMed
Metagegevens
Titel
A review of the application, feasibility, and the psychometric properties of the individualized measures in cancer
Auteurs
Ala’ S. Aburub
Nancy E. Mayo
Publicatiedatum
18-11-2016
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 5/2017
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-016-1458-4

Andere artikelen Uitgave 5/2017

Quality of Life Research 5/2017 Naar de uitgave

OriginalPaper

Evaluating and establishing national norms for mental wellbeing using the short Warwick–Edinburgh Mental Well-being Scale (SWEMWBS): findings from the Health Survey for England

OriginalPaper

Neonatal risk mortality scores as predictors for health-related quality of life of infants treated in NICU: a prospective cross-sectional study

OriginalPaper

Development of the forensic inpatient quality of life questionnaire: short version (FQL-SV)

OriginalPaper

Factors associated with the quality of life of mothers of preterm infants with very low birth weight: a 3-year follow-up study

OriginalPaper

The validation of a computer-adaptive test (CAT) for assessing health-related quality of life in children and adolescents in a clinical sample: study design, methods and first results of the Kids-CAT study

OriginalPaper

The impact of living arrangements on quality of life among Korean elderly: findings from the Korean Longitudinal Study of Aging (2006–2012)